The State of Biopharma: Navigating a Stormy Climate – July 26th, 2022
The State of Biopharma: Navigating a Stormy Climate – July 26th, 2022 Click Here for a full summary of the […]
Locust Walk Webinar
Locust Walk Webinar
Biotech Is Down But Not Out: Developing A Game Plan In A Volatile Market – April 27th, 2022
Biotech Is Down But Not Out: Developing A Game Plan In A Volatile Market – April 27th, 2022 Click Here for
Locust Walk Webinar
Locust Walk Stem Cell Tx Conference in partnership with Harvard Stem Cell Institute – April 11th, 2022
Locust Walk Stem Cell Tx Conference in partnership with Harvard Stem Cell Institute April 11th, 2022, Conference in Review We
Podcast
Biotalk Episode 16: A Conversation with Stephen Sands of Lazard
On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Stephen Sands, former Vice Chairman of Investment Banking and Chairman of the Global
Locust Walk Insights
Boston Business Journal: Life sciences firm Locust Walk’s plans for its $175M SPAC
Life sciences firm Locust Walk’s plans for its $175M SPAC Geoff Meyerson co-founded Locust Walk, a Boston-based life sciences consulting
Locust Walk Insights
Biopharma’s COVID Capital Comeback
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
Uncategorized
Rapid micro
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO AN EQUITY INVESTMENT Situation Assessment Rapid Micro Biosystems is a privately held, commercial
Uncategorized
Chimerix symbio case study
Transaction Case Studies GLOBAL DEAL WITH A JAPANESE COMPANY FOR BRINCIDOFOVIR, A BROAD-SPECTRUM ANTIVIRAL FOR THE TREATMENT AND PREVENTION OF
Uncategorized
Anokion and kanyos
Transaction Case Studies RAPID M&A ADVISORY Situation Assessment Anokion Bio is Swiss biotechnology company focused on autoimmune diseases by restoring
Uncategorized
Xyphos case study
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO ACQUISITION OF XYPHOS BY ASTELLAS FOR $120M UPFRONT AND $545M IN MILESTONE PAYMENTS